Smoking and outcomes after knee and hip arthroplasty: A systematic review

Journal of Rheumatology

Volumn 38, Issue 9, 2011, Pages 1824-1834

  Singh, Jasvinder A ^a,b,c,d  

^a University of Alabama at Birmingham   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^c VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Arthroplasty; Outcomes; Smoking; Total hip arthroplasty; Total knee arthroplasty

Indexed keywords

CIGARETTE SMOKING; COHORT ANALYSIS; HUMAN; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; SMOKING CESSATION; SURGICAL RISK; SYSTEMATIC REVIEW; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME;

ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; COMORBIDITY; HUMANS; POSTOPERATIVE COMPLICATIONS; SMOKING; TREATMENT OUTCOME;

EID: 80052316876     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.101221     Document Type: Review

References (69)

1. Ethgen O, Bruyere O, Richy F, Dardennes C, Reginster JY. Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am 2004;86:963-74. (Pubitemid 38619796)
2. Jones CA, Voaklander DC, Johnston DW, Suarez-Almazor ME. Health related quality of life outcomes after total hip and knee arthroplasties in a community based population. J Rheumatol 2000;27:1745-52. (Pubitemid 30462822)
3. Agabiti N, Picciotto S, Cesaroni G, Bisanti L, Forastiere F, Onorati R, et al. The influence of socioeconomic status on utilization and outcomes of elective total hip replacement: a multicity population-based longitudinal study. Int J Qual Health Care 2007;19:37-44. (Pubitemid 46237989)
4. Singh JA, Gabriel S, Lewallen D. The impact of gender, age, and preoperative pain severity on pain after TKA. Clin Orthop Relat Res 2008;466:2717-23.
5. Singh JA, Lewallen D. Age, gender, obesity, and depression are associated with patient-related pain and function outcome after revision total hip arthroplasty. Clin Rheumatol 2009;28:1419-30.
6. Singh JA, Gabriel SE, Lewallen DG. Higher body mass index is not associated with worse pain outcomes after primary or revision total knee arthroplasty. J Arthroplasty 2011;26:366-74.
7. Singh JA, Lewallen D. Predictors of pain and use of pain medications following primary total hip arthroplasty (THA): 5,707 THAs at 2-years and 3,289 THAs at 5-years. BMC Musculoskelet Disord 2010;11:90.
8. Singh JA, O'Byrne M, Harmsen S, Lewallen D. Predictors of moderate-severe functional limitation after primary total knee arthroplasty (TKA): 4701 TKAs at 2-years and 2935 TKAs at 5-years. Osteoarthritis Cartilage 2010;18:515-21.
9. Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview. CMAJ 2009;181:787-96.
10. Glassman SD, Anagnost SC, Parker A, Burke D, Johnson JR, Dimar JR. The effect of cigarette smoking and smoking cessation on spinal fusion. Spine 2000;25:2608-15.
11. W-Dahl A, Toksvig-Larsen S. Cigarette smoking delays bone healing: a prospective study of 200 patients operated on by the hemicallotasis technique. Acta Orthop Scand 2004;75:347-51.
12. Lefebvre C, Manheimer E, Glanville J. Searching for studies. Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions; version 5.0.2 [updated September 2009]: The Cochrane Collaboration. [Internet. Accessed April 7, 2010.] Available from: www.cochrane-handbook.org
13. Singh JA, Noorbaloochi S, Singh G. Golimumab for rheumatoid arthritis: a systematic review. J Rheumatol 2010;37:1096-104.
14. Singh JA, Beg S, Lopez-Olivo MA. Tocilizumab for rheumatoid arthritis: A Cochrane systematic review. J Rheumatol 2011;38:10-20.
15. Mertens M, Singh JA. Anakinra for rheumatoid arthritis. Cochrane Database Syst Rev 2009:CD005121.
16. Singh JA, Noorbaloochi S, Singh G. Golimumab for rheumatoid arthritis. Cochrane Database Syst Rev 2010:CD008341.
17. Maxwell LJ, Singh JA. Abatacept for rheumatoid arthritis: A Cochrane systematic review. J Rheumatol 2010;37:234-45.
18. Thomsen T, Villebro N, Moller AM. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev 2010:CD002294.
19. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute; 2003. [Internet. Accessed April 7, 2010.] Available from: http://www.ohri.ca/programs/clinical- epidemiology/oxford.asp
20. Cates C. Visual Rx NNT calculator version 3. Dr. Chris Cates'EBM web site. [Internet. Accessed April 7, 2010.] Available from: http://www.Nntonline. Net/visualrx/
21. Kozak E. A preoperative smoking intervention decreased postoperative complications in elective knee or hip replacement. ACP J Club 2002;137:7.
22. Barry H. Is it worth trying to get smokers to quit before elective surgery? Evidence-Based Practice 2002;5:5.
23. Murray EW. A preoperative smoking intervention decreased postoperative complications in elective knee or hip replacement. Evidence-Based Nursing 2002;5:84.
24. Myles PS. Should smokers be referred to a smoking-cessation clinic before undergoing elective surgery? Med J Aust 2004;180:126-7. (Pubitemid 38173108)
25. Petty TL. How to blow your defense. Chest 2002;122:1868-9.
26. Vince K, Chivas D, Droll KP. Wound complications after total knee arthroplasty. J Arthroplasty 2007;22:39-44. (Pubitemid 47001317)
27. Tonnesen H, Moller AM. [The smoking and drinking patient]. Ugeskr Laeger 2006;168:4293-6.
28. Bullock DP, Sporer SM, Shirreffs TG Jr. Comparison of simultaneous bilateral with unilateral total knee arthroplasty in terms of perioperative complications. J Bone Joint Surg Am 2003;85:1981-6. (Pubitemid 37259736)
29. Gaston MS, Amin A, Clayton RA, Hannah H, Brenkel I. Single-stage bilateral cemented total hip replacement: Is it safe and effective? Eur J Orthop Surg Trauma 2007;17:57-60.
30. Horne G, Devane P, Davidson A, Adams K, Purdie G. The influence of steroid injections on the incidence of infection following total knee arthroplasty. NZ Med J 2008;121:U2896.
31. Moller AM, Pedersen T, Villebro N, Norgaard P. Impact of lifestyle on perioperative smoking cessation and postoperative complication rate. Prev Med 2003;36:704-9. (Pubitemid 36559589)
32. Wolfe F, Zwillich SH. The long-term outcomes of rheumatoid arthritis: A 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis Rheum 1998;41:1072-82. (Pubitemid 28265410)
33. Khuri SF, Daley J, Henderson W, Barbour G, Lowry P, Irvin G, et al. The National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment of the quality of surgical care. J Am Coll Surg 1995;180:519-31.
34. Rodionova SS, Nuzhdin VI, Kliushnichenko IV, Krivova AV, Turgumbaev TN. [Smoking and alcohol abuse, risk factors of aseptic instability of hip endoprostheses]. Vestn Ross Akad Med Nauk 2008;9:6-12.
35. Iturbe Hernandez T, de Miguel Olmeda R, Cornudella Lacasa R, Gutierrez Martin M. [Total hip and knee arthroplasty: do obese patients or smokers require a more prolonged thrombosis prophylaxis?]. Rev Clin Esp 1999;199:550-1.
36. Moller AM, Kjellberg J, Pedersen T. [Health economic analysis of smoking cessation prior to surgery - based on a randomised trial]. Ugeskr Laeger 2006;168:1026-30.
37. Moller AM, Villebro NM. [Preoperative smoking intervention: What do patients think? A qualitative study]. Ugeskr Laeger 2004;166:3714-8.
38. Cavanaugh ME. Recovery of total knee arthroplasty: Smoker versus non-smoker. Vol M.S. United States. New York: D'Youville College; 1997:57.
39. Davis FM, Laurenson VG, Gillespie WJ, Wells JE, Foate J, Newman E. Deep vein thrombosis after total hip replacement. A comparison between spinal and general anaesthesia. J Bone Joint Surg Br 1989;71:181-5. (Pubitemid 19081387)
40. Lindstrom D, Sadr Azodi O, Wladis A, Tonnesen H, Linder S, Nasell H, et al. Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial. Ann Surg 2008;248:739-45.
41. Moller AM, Villebro N, Pedersen T, Tonnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002;359:114-7. (Pubitemid 34112539)
42. Spaar A. Does preoperative smoking cessation protect from postoperative complications? [German]. Praxis 2009;98:721-2.
43. Peersman G, Laskin R, Davis J, Peterson M. Infection in total knee replacement: A retrospective review of 6489 total knee replacements. Clin Orthop Relat Res 2001;392:15-23. (Pubitemid 33054925)
44. Delis KT, Hunt N, Strachan RK, Nicolaides AN. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy. Thromb Haemost 2001;86:817-21. (Pubitemid 32834191)
45. Sadr Azodi O, Bellocco R, Eriksson K, Adami J. The impact of tobacco use and body mass index on the length of stay in hospital and the risk of post-operative complications among patients undergoing total hip replacement. J Bone Joint Surg Br 2006;88:1316-20. (Pubitemid 44613146)
46. Lavernia CJ, Sierra RJ, Gomez-Marin O. Smoking and joint replacement: resource consumption and short-term outcome. Clin Orthop Relat Res 1999;367:172-80. (Pubitemid 29503692)
47. Fisher DA, Dierckman B, Watts MR, Davis K. Looks good but feels bad: factors that contribute to poor results after total knee arthroplasty. J Arthroplasty 2007;22:39-42. (Pubitemid 47333016)
48. Moller AM, Pedersen T, Villebro N, Munksgaard A. Effect of smoking on early complications after elective orthopaedic surgery. J Bone Joint Surg 2003;85:178-81. (Pubitemid 36410536)
49. Espehaug B, Havelin LI, Engesaeter LB, Langeland N, Vollset SE. Patient-related risk factors for early revision of total hip replacements. A population register-based case-control study of 674 revised hips. Acta Orthop Scand 1997;68:207-15.
50. Sadr Azodi O, Adami J, Lindstrom D, Eriksson KO, Wladis A, Bellocco R. High body mass index is associated with increased risk of implant dislocation following primary total hip replacement: 2,106 patients followed for up to 8 years. Acta Orthop 2008;79:141-7. (Pubitemid 351271896)
51. Meldrum RD, Wurtz LD, Feinberg JR, Capello WN. Does smoking affect implant survivorship in total hip arthroplasty? A preliminary retrospective case series. Iowa Orthop J 2005;25:17-24.
52. Bischoff-Ferrari HA, Lingard EA, Losina E, Baron JA, Roos EM, Phillips CB, et al. Psychosocial and geriatric correlates of functional status after total hip replacement. Arthritis Rheum 2004;51:829-35. (Pubitemid 39377768)
53. Anderson L, Kammerer WS, Greer RB 3rd. Risk factor assessment in 101 total hip arthroplasties: a medical perspective. Clin Orthop Relat Res 1979;141:50-4. (Pubitemid 10233169)
54. Beksac B, Gonzalez Della Valle A, Salvati EA. Thromboembolic disease after total hip arthroplasty: who is at risk? Clin Orthop Relat Res 2006;453:211-24. (Pubitemid 44900986)
55. Sharrock NE, Hargett MJ, Urquhart B, Peterson MG, Ranawat C, Insall J, et al. Factors affecting deep vein thrombosis rate following total knee arthroplasty under epidural anesthesia. J Arthroplasty 1993;8:133-9. (Pubitemid 23112663)
56. Horne G, Culliford N, Adams K, Devane P. Hybrid total hip replacement: outcome after a mean follow up of 10 years. A NZ J Surg2007;77:638-41.
57. Malinzak RA, Ritter MA. Postoperative wound infection: 35 years of experience. Orthopedics 2006;29:797-8. (Pubitemid 44468653)
58. Cates HE, Schmidt JM. Closed manipulation after total knee arthroplasty: outcome and affecting variables. Orthopedics 2009;32:398.
59. Grosflam JM, Wright EA, Cleary PD, Katz JN. Predictors of blood loss during total hip replacement surgery. Arthritis Care Res 1995;8:167-73.
60. Inoue K, Ushiyama T, Tani Y, Hukuda S. Sociodemographic factors and failure of hip arthroplasty. Int Orthop 1999;23:330-3. (Pubitemid 30103277)
61. Nixon M, Taylor G, Sheldon P, Iqbal SJ, Harper W. Does bone quality predict loosening of cemented total hip replacements? J Bone Joint Surg Bri 2007;89:1303-8. (Pubitemid 350157310)
62. Khan LAK, Cowie JG, Ballantyne JA, Brenkel IJ. The complication rate and medium-term functional outcome after total hip replacement in smokers. Hip Int 2009;19:47-51.
63. Malik MHA, Gray J, Kay PR. Early aseptic loosening of cemented total hip arthroplasty: the influence of non-steroidal anti-inflammatory drugs and smoking. Int Orthop 2004;28:211-3. (Pubitemid 39150315)
64. Peersman G, Laskin R, Davis J, Peterson M. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res 2001;392:15-23. (Pubitemid 33054925)
65. Hejblum G, Atsou K, Dautzenberg B, Chouaid C. Cost-benefit analysis of a simulated institution-based preoperative smoking cessation intervention in patients undergoing total hip and knee arthroplasties in France. Chest 2009;135:477-83.
66. Warner DO. Tobacco dependence in surgical patients. Curr Opin Anaesthesiol 2007;20:279-83. (Pubitemid 46701345)
67. Singh JA, Kundukulam J, Riddle DL, Strand CV, Tugwell P. Early postoperative mortality following joint arthroplasty: A systematic review. J Rheumatol 2011; (in press).
68. Oliver MN, Sheufelt J, Deshpande P, Grandage KK, St. Anna L, Hansen L. Clinical inquiries. Which postmenopausal women should be offered combined HRT? J Fam Pract 2003;52:149-50. (Pubitemid 36188093)
69. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33. (Pubitemid 34761611)